Contrast Induced Nephropathy (CIN) Completed Phase 2 / 3 Trials for Sodium bicarbonate (DB01390)

Also known as: Contrast Induced Nephropathy

IndicationStatusPhase
DBCOND0066353 (Contrast Induced Nephropathy (CIN))Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00497328COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasTPrevention